Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 185.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 248.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 46.02m
  • Volume: 0
  • Market Cap: 85.13m
  • Beta: 0.01

Ergomed Overview

Ergomed is in the pharma and biotech sector and is currently trading at 185.00p per share. In the last year Ergomed 's share price has ranged from 147.50p to 248.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (21-02-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -8.2% 1.0%
ROCE n/a  
Latest F'cast
P/E 44.0 151.6
PEG n/a n/a
Pr/Revenue 1.8 1.6
Pr/Book 2.4  
Latest F'cast
Revenue 21.4% 13.3%
PBT n/a n/a
EPS -38.2% -71.0%
DPS n/a n/a

Ergomed Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Ergomed Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 53.94 0.55 1.22p 151.6 n/a -71% n/a 0.0%
31-Dec-19 61.28 5.32 9.54p 19.4 0.0 +682% n/a 0.0%
31-Dec-20 67.97 7.59 13.18p 14.0 0.4 +38% n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Ergomed Company Announcements

Proposed Board and Management Changes 13-Feb-2019 07:00 RNS
Exercise of Options & Issue of Equity 01-Feb-2019 11:31 RNS
Holding(s) in Company 31-Jan-2019 16:07 RNS

Latest Ergomed Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Ergomed Market Data

Currency UK Pounds
Share Price 185.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 248.00
52 Week Low 147.50
Volume 0
Shares Issued 46.02m
Market Cap 85.13m
Beta 0.01

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.09% below the market average69.09% below the market average69.09% below the market average69.09% below the market average69.09% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average
Price Trend
4.46% above the market average4.46% above the market average4.46% above the market average4.46% above the market average4.46% above the market average
56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average
Income Not Available
Growth
33.05% above the market average33.05% above the market average33.05% above the market average33.05% above the market average33.05% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

Ergomed Key Personnel

COO Jan Petracek
CFO Stuart Jackson

Top of Page